on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its stake in Mural Oncology plc. The document, dated 20 November 2025, pertains to Rule 8.3 of the Irish Takeover Panel Act, 1997. The form reveals that The Vanguard Group holds 288,891 ordinary shares in Mural Oncology, equating to a 1.67% interest.
No additional disclosures are being made concerning other offer parties. Recent transactions include the purchase of 32 shares at $2.08 each. No cash-settled or stock-settled derivative activities were disclosed. The document also states no indemnity or option arrangements exist, nor are there any related agreements. A Supplemental Form 8 is not attached.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news